People · Operator
Named in public records as an officer, director or promoter · active 2021–2026 · Other Health Care, Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Paradromics, Inc. | — | Other Health Care | Series C | $96.9M | $569.6M | 2021 |
| Gilgamesh Pharma Inc. | — | Pharmaceuticals | Series C | $72.7M | $10.8M | 2026 |
| Gilgamesh Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $51.8M | $223.1M | 2021 |
| Cognixion Inc. | — | Other | Series A | $31.5M | $11.5M | 2021 |
Amy Kruse at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Amy Kruse on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Berman | 2 | 4 |
| Zia Huque | 2 | 3 |
| Andrew Kruegel | 2 | 2 |
| Phil Skolnick | 2 | 2 |
| Jonathan Sporn | 2 | 2 |
| Dakin Sloss | 1 | 9 |
| Adam Kablanian | 1 | 3 |
| Thomas Krummel | 1 | 3 |
| Tom Washing | 1 | 3 |
| Diana Pereira | 1 | 3 |
| Ron Kelly | 1 | 3 |
| THOMAS WASHING | 1 | 3 |
| Jeffrey Kraut | 1 | 2 |
| Thomas Gruber | 1 | 2 |
| Helmy Eltoukhy | 1 | 2 |
| James Burrows | 1 | 2 |
| Thomas G Washing | 1 | 1 |
| Matt Angle | 1 | 1 |
| Thomas Ladd | 1 | 1 |
| Leonard Zerman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.